S100A2 and colorectal cancer: S100A2 activates the phosphoinositide 3-kinase (PI3K)/AKT serine/threonine kinase (AKT) signaling pathway and upregulates GLUT1 expression, which induces glycolytic reprogramming and consequently increases the proliferation of colorectal cancer cells in vitro [101].